A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

NCT00000774 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

156

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
HIV Seronegativity

Interventions

BIOLOGICAL: rgp120/HIV-1MN
BIOLOGICAL: rgp120/HIV-1 SF-2
BIOLOGICAL: Placebo version of rgp120/HIV-1MN
BIOLOGICAL: Placebo version of rgp120/HIV-1SF2

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]